(2s,4r)-4-Fluoropyrrolidine-2-carboxamide hydrochloride, 95+%, 250mg

4-Bromo-2,6-pyridinedicarboxylic Acid Monohydrate>98.0%(GC)(T)200mg

6-Nitro-2H-chromen-2-one, 95.0%, 250mg

1,3-Bis(3,3,3-trifluoropropyl)-1,1,3,3-tetramethyldisilazane>94.0%(GC)5g

tert-Butyl 1-oxa-4-azaspiro[5.5]undecane-4-carboxylate, 97%, 2g

4-Bromo-2-fluorophenol, 98.0%, 100g

2-Mercapto-5-nitropyridine>98.0%(T)25g

(S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetonitrile hydrobromide, 97%, 250mg

1-(3-Chloropropyl)pyrrolidine hydrochloride, 95.0%, 5g

Anti-GalNAc-GD1a Monoclonal Antibody (2A3D2)1vial

3-Bromobicyclo[4.2.0]octa-1,3,5-triene, 95.0%, 100g

5-chloro-3-(4-chlorophenyl)-2-fluoropyridine, 95+%, 500mg

4-Bromo-6-methylpicolinic acid, 95.0%, 1g